External links
   | This biographical article related to a physician in the United States is a stub. You can help Wikipedia by expanding it. |
Monica Morrow | |
|---|---|
| Occupation | Surgeon |
| Awards | Komen Brinker Award for Scientific Distinction (2016) [1] |
Monica Morrow is a breast cancer surgeon and Chief of Breast Surgery at Memorial Sloan-Kettering Cancer Center in Manhattan, NY. [2] Her first day seeing patients in clinic as Chief at MSKCC was Tuesday, February 19, 2008. She formerly served as the chairman of surgical oncology at the Fox Chase Cancer Center. She is the President-elect of the Society for Surgical Oncology.
In 2005 she was elected to the Royal College of Physicians and Surgeons of Glasgow. And in 2004 the Chicago Sun-Times named Morrow one of the top 20 most powerful women in health care in Chicago. [3]
Morrow served on the National Cancer Policy Board for three years until 2002. She was the first surgeon to do so. She is the author of several books on breast cancer for both researchers and the general public.
Morrow graduated with a BS degree from Pennsylvania State University, received her MD degree from Jefferson Medical College in 1976, served her general surgery residency at the Medical Center Hospital of Vermont and completed a surgical oncology fellowship at Memorial Sloan-Kettering Cancer Center in 1983.
In 1988 Morrow became an associate professor of surgery at the University of Chicago and also director of the multidisciplinary breast cancer team. In 1993 she joined the faculty at Northwestern University as Professor of Surgery and director of the Lynn Sage Comprehensive Breast Center.
| | This biographical article related to a physician in the United States is a stub. You can help Wikipedia by expanding it. |
Memorial Sloan Kettering Cancer Center is a cancer treatment and research institution in New York City, founded in 1884 as the New York Cancer Hospital. MSKCC is the largest and oldest private cancer center in the world, and is one of 51 National Cancer Institute–designated Comprehensive Cancer Centers. Its main campus is located at 1275 York Avenue, between 67th and 68th streets, in Manhattan.
Josep Baselga i Torres, known in Spanish as José Baselga was a Spanish medical oncologist and researcher focused on the development of novel molecular targeted agents, with a special emphasis in breast cancer. Through his career he was associated with the Memorial Sloan Kettering Cancer Center, Vall d'Hebron Institute of Oncology, and the Massachusetts General Hospital in their hematology and oncology divisions. He led the development of the breast cancer treatment Herceptin, a monoclonal antibody, that targets the HER2 protein which is impacted in aggressive breast cancers.
The American College of Surgeons (ACS) is an educational association of surgeons founded in 1912. Headquartered in Chicago, Illinois, it was founded by Frederic Atwood Besley, MD, FCAS, a military surgeon. The ACS provides membership for doctors worldwide specializing in surgery who pass a set of rigorous qualifications.
Kathie-Ann Joseph is a surgeon and researcher at New York University Langone Health where she specializes in breast surgery and oncology surgery. Joseph is also the chief of breast surgery at Bellevue Medical Center, where she was recognized in 2015 as Bellevue's Physician of the Year. Joseph works to reduce disparities in cancer care in order to improve health care for individuals in need. Specifically, Joseph focuses on developing programs that will help African-American women to address their needs in breast cancer prevention and care. She is also studying the effects of a cell surface receptor molecule called RAGE which appears to play a role in tumor growth.
Breast-conserving surgery (BCS) refers to an operation that aims to remove breast cancer while avoiding a mastectomy. Other terms for this operation include: lumpectomy, wide local excision, segmental resection, tylectomy, and quadrantectomy. BCS has been increasingly accepted as an alternative to mastectomy in specific patients, as it provides tumor removal while maintaining an acceptable cosmetic outcome. This page reviews the history of this operation, important considerations in decision making and patient selection, and the emerging field of oncoplastic breast conservation surgery.
William S. Breitbart, FAPM, is an American psychiatrist in Psychosomatic Medicine, Psycho-oncology, and Palliative Care. He is the Jimmie C Holland Chair in Psychiatric Oncology, and the Chief of the Psychiatry Service, Department of Psychiatry and Behavioral Sciences, Memorial Sloan-Kettering Cancer Center, He is a Professor of Clinical Psychiatry at Weill Medical College of Cornell University. He was president of the Academy of Psychosomatic Medicine, and the Editor-in-Chief of Palliative and Supportive Care.
Jonathan J. Lewis, M.D., Ph.D., is a surgeon, biomedical researcher and entrepreneur. He was trained in surgery in South Africa, Britain, and the United States, and is a fellow of both the Royal College of Surgeons and the American College of Surgeons. Dr. Lewis was awarded an MB.B.Ch. from University of the Witwatersrand School of Medicine, and his Ph.D. in Molecular Biology from Witwatersrand and Yale School of Medicine. He completed his Surgical Residency at Charlotte Maxeke Johannesburg Academic Hospital and at Yale-New Haven Hospital. Lewis was a Professor of Surgery and Medicine Memorial Sloan-Kettering Cancer Center, before working in the biotechnology and healthcare industries, serving in several CEO and Chairman roles. He is currently chairman and co-founder of the Molecular Ninja Group and chairman and co-founder of Dugri Inc.
T. Narayana Rao M.B.B.S., MS FICS, FACS, FRCS Glasgow is Professor of Surgery, Andhra Medical College, and chief surgeon at King George Hospital, bariatric surgeon of Visakhapatnam. Started Visakha Obesity Surgery Center and Member of Governing Council and Hon Jn secretary of ASSOCIATION of Surgeons of India.
Jerome Urban (1914-1991) was an American surgical oncologist who promoted superradical mastectomies until 1963, when the lack of difference in ten-year survival rates convinced him that it worked no better than the less-mutilating radical mastectomy.
Robert E. Wittes was Physician-in-Chief of Memorial Sloan-Kettering Cancer Center, from 2002 until December 31, 2012. Prior to his appointment at MSKCC, he was Deputy Director for Extramural Sciences and Director of the Division of Cancer Treatment and Diagnosis at the National Cancer Institute, where he oversaw NCI's extramural clinical and basic research programs, including the evaluation of new therapeutics, diagnostics, and translational research. Wittes is a fellow of the American College of Physicians, a member of the American Association for Cancer Research, the American Society of Clinical Oncology, and the American Federation for Medical Research. In addition to his institutional affiliations, Dr. Wittes has served as editor-in-chief of the Journal of the National Cancer Institute and Oncology. He has served on the editorial boards of Clinical Cancer Research, Current Opinion in Oncology, The American Journal of Clinical Oncology; Cancer Investigation, and The International Journal of Radiation Oncology-Biology & Physics, among others.
George Bosl is an American cancer researcher, holder of the Patrick M. Byrne Chair in Clinical Oncology at the Memorial Sloan-Kettering Cancer Center in New York City, and is a Professor of Medicine at the Weill Cornell Medical College. In 1997 he was appointed chair of the Department of Medicine at Sloan-Kettering.
Peter T. Scardino is an American cancer surgeon, researcher, and author expert in genitourinary and urological cancers particularly cancer of the prostate. He is chair of the Department of Surgery at Memorial Sloan Kettering Cancer Center.
John H. Healey is an American cancer surgeon, researcher, and expert in the surgical treatment of benign and malignant bone tumors and other musculoskeletal cancers. He serves as Chair of the Orthopaedic Service and Stephen P. McDermott Chair in Surgery at Memorial Sloan-Kettering Cancer Center (MSKCC), as well as Professor of Surgery at Weill Cornell Medical College, in New York, NY.
Gregory Bruce Mann is a surgical oncologist and Director of Breast Cancer Services at the Royal Women's Hospital in Melbourne, Australia, the largest specialist women's care hospital in Australia. A former president of COSA, Dr. Mann served previously as Director of Cancer Services and Infectious Medicine for the Melbourne Health Cancer Service, as Director of the award-winning Melbourne Health Combined Breast Service and is Director of Advanced Surgical Training at the Royal Melbourne Hospital. The Combined Breast Service won the prestigious Premier's Award for "Excellence for improving cancer care in Victoria" under Mann's direction in 2008.
Kenneth Offit is an American cancer geneticist and oncologist. He is currently Chief of the Clinical Genetics Service at Memorial Sloan Kettering Cancer Center, a member of the Program in Cancer Biology and Genetics at the Sloan-Kettering Institute, and Professor of Medicine and Healthcare Policy and Research at Weill Cornell Medical College. He is also a member of both the Board of Scientific Counselors of the National Cancer Institute and the Evaluation of Genomic Applications in Practice and Prevention working group of the U.S. Centers for Disease Control. In 2016, he was elected as a Member of the National Academy of Medicine. In 2018, he was named a Fellow of the American Society of Clinical Oncology.
LaSalle Doheny Leffall Jr. was an American surgeon, oncologist, and medical educator. Leffall was very committed to those he served and his profession. He served as the Charles R. Drew Professor of Surgery at Howard University College of Medicine and in leadership positions for several healthcare organizations, including stints as president of the American Cancer Society and the American College of Surgeons.
Raghu Ram Pillarisetti is an Indian surgeon, the youngest recipient of the Overseas Gold Medal of the Royal College of Surgeons of Edinburgh and the Founder-Director of KIMS-Ushalakshmi Center for Breast Diseases at KIMS Hospitals, the first dedicated and comprehensive facility for breast healthcare in the Indian subcontinent. He is also the Founder of Ushalakshmi Breast Cancer Foundation, a not for profit organisation working in tandem with government and non government bodies for spreading awareness about breast cancer and Pink Connexion, the first newsletter from India, a quarterly, about breast healthcare.
Jack E. White was an American physician and cancer surgeon. The first black physician to train in surgical oncology at Memorial Sloan Kettering Cancer Center, White later directed the cancer center at Howard University College of Medicine. He was elected to the Institute of Medicine in 1977.
Jeffrey Drebin is a surgeon and scientist. He serves as the Department of Surgery Chair at Memorial Sloan Kettering.
Elisa Rush Port FACS is Associate Professor of Surgery at the Icahn School of Medicine at Mount Sinai Hospital, as well as cofounder and director of the Dubin Breast Center at the Tisch Cancer Institute at Mount Sinai Health System, since 2010. She has received four research grants, has served as an investigator or co-investigator on 15 clinical trials, published 44 peer-reviewed articles, and published a total of 12 book chapters and books. She has specialized in sentinel-node biopsy, a diagnostic method that determines cancer stages based on spread to regional lymph nodes, nipple sparing mastectomy, and the use of MRI for breast cancer.